QLi5 Therapeutics GmbH
PrivateLast Round
Corporate Funding
Dec 18, 2025
Total Funding Raised
$17.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QLi5 Therapeutics GmbH operates in Healthcare & Life Sciences and is based in Dortmund. Its latest recorded funding round was a Corporate Funding round in December 2025.
QLi5 Therapeutics GmbH is a biotechnology company that develops a next-generation platform of non-covalent proteasome inhibitors for the treatment of cancer, inflammatory, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QLi5 Therapeutics GmbH Comparables
Compare QLi5 Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iProtics | 82% | |
| IpiNovyx Bio | 79% | |
| Tripod Therapeutics | 75% |
For institutional investors. Book with your work email.
QLi5 Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 18, 2025 | ||||
| Series A | Sep 7, 2022 |
For institutional investors. Book with your work email.
QLi5 Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A |
| KTB Investment Group | Series A |
| Atinum Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$7.3M round led by Qurient Co. Ltd
For institutional investors. Book with your work email.
QLi5 Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about QLi5 Therapeutics GmbH's valuation, stock price, and market status.
Is QLi5 Therapeutics GmbH a public or private company?
QLi5 Therapeutics GmbH is a private company.
What is the current stock price of QLi5 Therapeutics GmbH?
QLi5 Therapeutics GmbH is a private company, so its shares have no public market price. Caplight tracks QLi5 Therapeutics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is QLi5 Therapeutics GmbH worth (valuation)?
Valuation information for QLi5 Therapeutics GmbH is not publicly available.
Can I buy QLi5 Therapeutics GmbH stock?
QLi5 Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was QLi5 Therapeutics GmbH's last funding round?
QLi5 Therapeutics GmbH's most recent funding round was Corporate Funding on December 18, 2025.
Who are the main investors in QLi5 Therapeutics GmbH?
Key investors in QLi5 Therapeutics GmbH include SV Investment, KTB Investment Group, Atinum Investment.
Will QLi5 Therapeutics GmbH IPO soon?
No public IPO plans have been announced for QLi5 Therapeutics GmbH.
How can I track QLi5 Therapeutics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in QLi5 Therapeutics GmbH's shares on secondary markets.